Related references
Note: Only part of the references are listed.Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils
Silvia Lorrio et al.
BRAIN RESEARCH (2009)
Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Maria Isabel Fernandez-Bachiller et al.
CHEMMEDCHEM (2009)
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
Russel J. Reiter et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Alzheimer's disease: new approaches to drug discovery
Maria L. Bolognesi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients
Kornelia Kedziora-Kornatowska et al.
JOURNAL OF PINEAL RESEARCH (2009)
Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease
James M. Olcese et al.
JOURNAL OF PINEAL RESEARCH (2009)
Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines
Ruediger Hardeland et al.
JOURNAL OF PINEAL RESEARCH (2009)
Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species
Fabienne Peyrot et al.
JOURNAL OF PINEAL RESEARCH (2008)
Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress
Arabinda Das et al.
JOURNAL OF PINEAL RESEARCH (2008)
Cytotoxicity of 1,2-diacetylbenzene in human neuroblastoma SHSY5Y cells is mediated by oxidative stress
Min-Sun Kim et al.
TOXICOLOGY (2008)
Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress
Javier Egea et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils
Silvia Lorrio et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells
Catherine R. McMillan et al.
NEUROSCIENCE LETTERS (2007)
A small molecule targeting the multifactorial nature of Alzheimer's disease
Andrea Cavalli et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis
Larisa Bobrovskaya et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment
Jochen H. Weishaupt et al.
JOURNAL OF PINEAL RESEARCH (2006)
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells:: Role of nicotinic receptors
E Arias et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
PI Moreira et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Indicators of neuroprotection with galantamine
H Geerts
BRAIN RESEARCH BULLETIN (2005)
Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity
YS Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity
T Kihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation
M Sobrado et al.
NEUROSCIENCE LETTERS (2004)
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors
E Arias et al.
NEUROPHARMACOLOGY (2004)
Regulation of antioxidant enzymes: a significant role for melatonin
C Rodriguez et al.
JOURNAL OF PINEAL RESEARCH (2004)
Combination therapy in Alzheimer's disease - A review of current evidence
B Schmitt et al.
CNS DRUGS (2004)
Oxidative stress, cell cycle, and neurodegeneration
JA Klein et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Melatonin: reducing the toxicity and increasing the efficacy of drugs
RJ Reiter et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Modulation of nicotinic receptor activity in the central nervous system: A novel approach to the treatment of Alzheimer disease
EX Albuquerque et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2001)
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration
J Herrera et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease
A Maelicke et al.
BIOLOGICAL PSYCHIATRY (2001)
Biochemical reactivity of melatonin with reactive oxygen and nitrogen species - A review of the evidence
RJ Reiter et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2
RA Osseni et al.
LIFE SCIENCES (2000)
Melatonin directly scavenges hydrogen peroxide: A potentially new metabolic pathway of melatonin biotransformation
DX Tan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
